Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus: systematic review and meta-analysis of cardiovascular outcomes trials
Adjustments to your diabetes treatment plan may be necessary to avoid dangerous drops in blood sugar
Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial
He further utilizes the latest research and documented clinical studies to provide safe and effective weight loss and anti-aging therapies to his patients
In 2023, the FDA approved another GLP-1 drug for weight loss, tirzepatide, under the brand name Zepbound
EA rival Take-Two has taken a different approach, with CEO Strauss Zelnick recently saying the company was not at risk of doing brand partnerships in the forthcoming Grand Theft Auto VI, and that ads in full-price games seems unfair. The $55 billion deal to take EA private, led by Saudi Arabias Public Investment Fund, is set to close at the end of this month
